Passage Bio, Inc.

Historical 13F Holders

Symbol
PASG
CUSIP
702712100
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 702712100 since 12/18/2024, largest first.

Filer % of Class Filed
Lynx1 Capital Management LP 13D
21.0% 7/2/2026
Event 6/25/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Erste Asset Management GmbH 13G/A 4.4% 11/14/2024
Event 3/31/2024
Orbimed Advisors LLC 13D/A
4.3% 7/24/2025
Event 7/22/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 2 87.4 k $702k
2025 Q2 41 35.1 M $33.0M
2025 Q1 44 36.3 M $12.8M
2024 Q4 48 37.6 M $21.6M
2024 Q3 46 38.7 M $27.1M
2024 Q2 46 40.3 M $32.0M
2024 Q1 52 40.3 M $54.4M
2023 Q4 53 32.8 M $33.1M
2023 Q3 52 32.4 M $21.3M
2023 Q2 57 33.4 M $31.4M
2023 Q1 60 35.5 M $34.0M
2022 Q4 69 37.4 M $51.6M
2022 Q3 77 39.4 M $49.3M
2022 Q2 88 42.2 M $99.6M
2022 Q1 111 43.0 M $133M
2021 Q4 104 43.7 M $278M
2021 Q3 105 42.1 M $419M
2021 Q2 103 44.6 M $559M
2021 Q1 91 45.0 M $786M
2020 Q4 72 32.0 M $818M
2020 Q3 71 30.8 M $403M
2020 Q2 67 31.6 M $863M
2020 Q1 46 29.2 M $458M